Categories

Brands

Active Ingredient

Warehouses

Stanozolol Information

Click here to view all Stanozolol products
2D Structure of Stanozolol
2D Structure
3D Structure of Stanozolol
3D Structure

Stanozolol, commonly known by its brand name Winstrol, is a synthetic anabolic-androgenic steroid (AAS). It is derived from dihydrotestosterone (DHT) and is known for its anabolic properties with reduced androgenic effects. Here are some details about stanozolol:

  • Anabolic Effects: Stanozolol exhibits potent anabolic effects, meaning it promotes muscle growth, protein synthesis, and nitrogen retention. These effects contribute to increased muscle mass, strength, and athletic performance.
  • Androgenic Effects: Stanozolol has relatively low androgenic activity compared to other AAS. This means it has a reduced likelihood of causing androgenic side effects such as acne, hair loss, and virilization in women.
  • Medical Uses: Stanozolol has been approved for medical use in humans, primarily for the treatment of hereditary angioedema, a condition characterized by recurrent episodes of swelling in various parts of the body. It has also been used for the treatment of certain types of anemia and to promote weight gain in patients experiencing weight loss.
  • Performance Enhancement: Stanozolol is popular among athletes and bodybuilders for its potential to enhance physical performance. It is commonly used during cutting cycles to help preserve lean muscle mass, improve muscle hardness, and promote a more defined physique.
  • Administration: Stanozolol is available in both oral and injectable forms. The oral form is the most common and convenient for users, while the injectable form has a longer duration of action and is less hepatotoxic (liver toxic) compared to the oral form.
  • Fat Loss: Stanozolol has been reported to have a mild fat-burning effect. It can help enhance metabolic rate and promote a leaner appearance by reducing subcutaneous water retention and improving muscle definition.
  • Side Effects: Like any other AAS, stanozolol carries the risk of potential side effects. These may include liver toxicity (especially with the oral form), cardiovascular strain, suppression of natural testosterone production, alterations in lipid profiles, joint discomfort, and potential masculinizing effects in women. It is important to use stanozolol under the guidance of a healthcare professional and in accordance with prescribed dosages to minimize risks and monitor for any adverse reactions.
  • Legal Status: The non-medical use of stanozolol is considered illegal in many countries without a valid prescription. It is classified as a controlled substance due to its potential for abuse and misuse. The laws and regulations surrounding stanozolol and other AAS can vary, so it's important to be aware of and comply with local laws and guidelines.

If you have any specific concerns or considerations regarding stanozolol, it is advisable to consult a healthcare professional or a qualified medical practitioner who can provide personalized advice and guidance.

 

How Stanozolol works?

Stanozolol, also known as Winstrol, works by binding to androgen receptors in various tissues throughout the body, including muscle cells. Once bound to these receptors, it initiates a series of cellular events that contribute to its effects. Here's how stanozolol works:

  1. Androgen Receptor Binding: Stanozolol enters the bloodstream after administration and binds to androgen receptors located inside cells, specifically in the nucleus. This binding stimulates the androgen receptors and initiates a cascade of cellular events.
  2. Protein Synthesis: Stanozolol promotes protein synthesis in muscle cells. Protein synthesis is the process by which cells build new proteins, including muscle proteins. Increased protein synthesis leads to muscle growth and repair, resulting in gains in muscle mass and strength.
  3. Nitrogen Retention: Stanozolol enhances nitrogen retention in muscle tissue. Nitrogen is an essential component of proteins, and a positive nitrogen balance promotes anabolism (muscle growth) by ensuring the body remains in a state of protein synthesis rather than protein breakdown.
  4. Red Blood Cell Production: Stanozolol can stimulate the production of red blood cells (erythropoiesis). This can increase the oxygen-carrying capacity of the blood, leading to improved endurance and stamina during physical activities.
  5. Enhanced Performance: Stanozolol is often used by athletes and bodybuilders to enhance performance. It can improve strength, speed, and overall athletic performance, making it popular for competitive endeavors.
  6. Anti-Estrogenic Effects: Stanozolol exhibits anti-estrogenic properties. It can competitively bind to estrogen receptors, preventing estrogen from exerting its effects. This can be beneficial during cutting cycles or when using aromatizable compounds, as it helps reduce water retention and minimize estrogen-related side effects.
  7. Androgenic Effects: Stanozolol has mild androgenic effects, contributing to the development and maintenance of male sexual characteristics. However, the androgenic effects of stanozolol are relatively lower compared to some other anabolic steroids, reducing the risk of androgenic side effects.

It's important to note that while stanozolol can provide certain benefits, it also carries the risk of potential side effects. These can include androgenic effects such as oily skin, acne, and accelerated hair loss in individuals predisposed to male pattern baldness. Additionally, the use of stanozolol can suppress natural testosterone production and impact lipid profiles. It should be used under the guidance of a healthcare professional and in accordance with prescribed dosages to minimize risks and optimize potential benefits.

If you have any specific concerns or considerations regarding stanozolol, it is advisable to consult a healthcare professional or a qualified medical practitioner who can provide personalized advice and guidance.

Synonyms of Stanozolol

  • stanozolol
  • Androstanazole
  • Winstrol
  • Androstanazol
  • 10418-03-8
  • Stromba
  • Stanazolol
  • Tevabolin
  • Winstrol Depot
  • Strombaject
  • Estazol
  • Winstroid
  • Winstrol V
  • Stanozololum
  • Estanozolol
  • Anabol
  • WIN 14833
  • Methylstanazol
  • Stanozolo
  • Stanozolol ciii
  • Stanozolol (1'H form)
  • Stanozolo [DCIT]
  • Androstanazole (VAN)
  • HSDB 3185
  • Stanozolol (2'H form)
  • Winstrol-V
  • Stanozololum [INN-Latin]
  • Estanozolol [INN-Spanish]
  • EINECS 233-894-8
  • UNII-4R1VB9P8V3
  • NSC 43193
  • NSC-43193
  • WIN-14833
  • NSC 233046
  • Androstanazolestanazol
  • 4R1VB9P8V3
  • CHEBI:9249
  • DTXSID3044128
  • 17-Methyl-2'H-5alpha-androst-2-eno(3,2-c)pyrazol-17beta-ol
  • NSC-233046
  • 2'H-Androst-2-eno(3,2-c)pyrazol-17-ol, 17-methyl-, (5alpha,17beta)-
  • 17-Methyl-5alpha-androstano(3,2-c)pyrazol-17beta-ol
  • 17-beta-Hydroxy-17-alpha-methylandrostano(3,2-c)pyrazole
  • 17beta-Hydroxy-17alpha-methyl-androstano(3,2-c)pyrazole
  • 17-Methylpyrazolo(4',3':2,3)-5alpha-androstan-17beta-ol
  • 17beta-Hydroxy-17-methyl-5alpha-androstano(3,2-c)pyrazole
  • DTXCID1024128
  • 17-Methyl-pyrazolo(4',3':2,3)-5alpha-androstan-17beta-ol
  • 17alpha-Methyl-17beta-hydroxy-5alpha-androstano(3,2-c)pyrazole
  • 2'H-5alpha-Androst-2-eno(3,2-c)pyrazol-17beta-ol, 17-methyl-
  • 2,3-(4',3'-Pyrazolo)-5alpha-androstan-17beta-ol, 17-methyl-
  • Stanozolol [USAN:BAN:INN:JAN]
  • NSC43193
  • WIN14833
  • 1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-Hexadecahydro-1,10a,12a-trimethylcyclopenta(7,8)-phenanthro(2,3-c)pyrazol-1-ol
  • Cyclopenta(7,8)phenanthro(2,3-c)pyrazol-1-ol, 1,2,3,3a,3b,4,5,5a,6,8,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethyl-
  • Stanozolol [USAN:USP:INN:BAN:JAN]
  • 1'H-Androstano(3,2-c)pyrazol-17-ol, 17-methyl-, (5-alpha,17-beta)-
  • STANOZOLOL (MART.)
  • STANOZOLOL [MART.]
  • (1S,3aS,3bR,5aS,10aS,10bS,12aS)-1,10a,12a-trimethyl-1,2,3,3a,3b,4,5,5a,6,8,10,10a,10b,11,12,12a-hexadecahydrocyclopenta[5,6]naphtho[1,2-f]indazol-1-ol
  • 302-96-5
  • Cyclopenta(7,8)phenanthro(2,3-c)pyrazol-1-ol, 1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethyl-
  • C21H32N2O
  • STANOZOLOL (EP MONOGRAPH)
  • STANOZOLOL [EP MONOGRAPH]
  • STANOZOLOL CIII (USP-RS)
  • STANOZOLOL CIII [USP-RS]
  • STANOZOLOL (USP MONOGRAPH)
  • STANOZOLOL [USP MONOGRAPH]
  • (1S,3aS,3bR,5aS,10aS,10bS,12aS)-1,10a,12a-trimethyl-1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydrocyclopenta[5,6]naphtho[1,2-f]indazol-1-ol
  • SR-05000001522
  • 17?-Methyl-5?-androstano[3,2-c]pyrazol-17?-ol
  • stanozololo
  • Stanazol
  • NSC233046
  • 1'H-Androstano[3,2-c]pyrazol-17-ol, 17-methyl-, (5.alpha.,17.beta.)-
  • 1'H-ANDROSTANO(3,2-C)PYRAZOL-17-OL, 17-METHYL-, (5.ALPHA.,17.BETA.)-
  • 17.BETA.-HYDROXY-17.ALPHA.-METHYL-5.ALPHA.-ANDROSTANO(3,2-C)PYRAZOLE
  • Winstrol (TN)
  • (1S,3aS,3bR,5aS,10aS,10bS,12aS)-1,10a,12a-trimethyl-1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydrocyclopenta(5,6)naphtho(1,2-f)indazol-1-ol
  • STANOZOLOL [MI]
  • STANOZOLOL [INN]
  • STANOZOLOL [JAN]
  • STANOZOLOL [HSDB]
  • STANOZOLOL [USAN]
  • STANOZOLOL [VANDF]
  • D08QKJ
  • STANOZOLOL [WHO-DD]
  • stanozolol--dea schedule iii
  • SCHEMBL44099
  • SCHEMBL44100
  • Stanozolol (JAN/USP/INN)
  • MLS001424321
  • 17-Methyl-2'H-5.alpha.-androst-2-eno(3,2-c)pyrazol-17.beta.-ol
  • Stanozolol, analytical standard
  • STANOZOLOL [GREEN BOOK]
  • C21H32N2O.CH4
  • CHEMBL2079587
  • STANOZOLOL [ORANGE BOOK]
  • GTPL10369
  • A14AA02
  • 2'H-Androst-2-eno[3,2-c]pyrazol-17-ol, 17-methyl-, (5.alpha.,17.beta.)-
  • HMS2052H11
  • HMS2090P03
  • HMS3713K06
  • Stanozolol [USAN:INN:BAN:JAN]
  • (1S,2S,10S,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,10.04,8.014,18]icosa-4(8),5-dien-17-ol
  • BCP12548
  • HY-B0899
  • Tox21_113993
  • AKOS005067278
  • Stanozolol 1.0 mg/ml in Acetonitrile
  • AM84316
  • CCG-101186
  • CCG-220452
  • CS-4363
  • CS-O-02374
  • DB06718
  • NC00436
  • NCGC00344550-01
  • AC-16140
  • AC-33164
  • AS-35198
  • CPD000058878
  • LS-19415
  • LS-19530
  • SMR000058878
  • CAS-10418-03-8
  • 17-METHYL-2H-5ALPHA-ANDROST-2-ENO
  • C07311
  • D00444
  • 17-Methyl-5a-androstano[3,2-c]pyrazol-17b-ol
  • 17BETA-HYDROXY-17ALPHA-METHYL-ANDROSTANO
  • AB00443942-03
  • AB00443942-05
  • SR-05000001522-1
  • SR-05000001522-2
  • W-108823
  • 17a-Methyl-17b-hydroxy-5a-androstano(3,2-c)pyrazole
  • 17b-Hydroxy-17-methyl-5a-androstano[3,2-c]pyrazole
  • 17b-Hydroxy-17a-methyl-5a-androstano[3,2-c]pyrazole
  • Q63409446
  • 17-Methyl-pyrazolo[4',3':2,3]-5a-androstan-17b-ol
  • 17-Methyl-1'H-5alpha-androstano[3,2-c]pyrazol-17beta-ol
  • Stanozolol, European Pharmacopoeia (EP) Reference Standard
  • (5a,17b)-17-methyl-2'H-Androst-2-eno[3,2-c]pyrazol-17-ol
  • 2,3'-Pyrazolo)-5.alpha.-androstan-17.beta.-ol, 17-methyl-
  • 5alpha-Androstane-17alpha-methyl-17beta-ol-[3,2-c]pyrazole
  • 17-METHYL-5.ALPHA.-ANDROSTANO(3,2-C)PYRAZOL-17.BETA.-OL
  • 17beta-HYDROXY-17alpha-METHYL-5alpha-ANDROSTANO(3,2-C)PYRAZOLE
  • 2'H-5a-Androst-2-eno[3,2-c]pyrazol-17b-ol, 17-methyl- (8CI)
  • (5-alpha,17-beta)-17-Methyl-2'H-androst-2-eno[3,2-c]pyrazol-17-ol
  • 1'H-ANDROSTANO(3,2-C)PYRAZOL-17-OL, 17-METHYL-, (5alpha,17beta)-
  • 17alpha-Methyl-17beta-hydroxy-5alpha-androst-2-eno(3,2-c)-pyrazole
  • 2'H-ANDROST-2-ENO(3,2-C)PYRAZOL-17-OL, 17-METHYL-, (5.ALPHA.,17.BETA.)
  • 2'H-ANDROST-2-ENO(3,2-C)PYRAZOL-17-OL, 17-METHYL-, (5alpha,17beta)
  • Cyclopenta[7,8]phenanthro[2,3-c]pyrazole, 2'H-androst-2-eno[3,2-c]pyrazol-17-ol deriv.
  • (1S,2S,10S,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.0^{2,10}.0^{4,8}.0^{14,18}]icosa-4(8),5-dien-17-ol
  • 1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethyl-Cyclopenta[7,8]phenanthro[2,3-c]pyrazol-1-ol
  • 1,2,3,3A,3B,4,5,5A,6,8,10,10A,10B,11,12,12A-HEXADECAHY DRO-1,10A,12A-TRIMETHYLCYCLOPENTA
  • 17966-55-1
  • 875293-72-4
  • Cyclopenta[7,3-c]pyrazol-1-ol, 1,2,3,3a,3b,4,5,5a,6,8,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethyl-

External Sources about Stanozolol

Click here to view all Stanozolol products